Stryker
Trade Stryker 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SYK
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.
SYK Key Statistics
Stock Snapshot
As of today, Stryker(SYK) shares are valued at $367.54. The company's market cap stands at 140.56B, with a P/E ratio of 48.26 and a dividend yield of 92.5%.
During the trading session on 2026-01-11, Stryker(SYK) shares reached a daily high of $370.75 and a low of $365.93. At a current price of $367.54, the stock is +0.4% higher than the low and still -0.9% under the high.
Trading volume for Stryker(SYK) stock has reached 2M, versus its average volume of 1.63M.
The stock's 52-week range extends from a low of $329.16 to a high of $406.19.
The stock's 52-week range extends from a low of $329.16 to a high of $406.19.
SYK News
Bernstein analyst Lee Hambright raised the firm’s price target on Stryker (SYK) to $465 from $450 and keeps an Outperform rating on the shares. After a low poin...
Raymond James’ upgrade of Stryker (SYK) to “Outperform” has put the stock back in focus after the firm highlighted five years of double digit organic revenue gr...
Stryker recently announced it will report its fourth-quarter and full-year 2025 results on January 29, 2026, alongside a webcast discussion of the figures. Thi...
Analyst ratings
81%
of 32 ratingsMore SYK News
Key Points Raymond James analyst Jayson Bedford upgrades Stryker stock to outperform today. The medical devices stock has grown sales at 10% or better for fiv...
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the mark...
Evercore ISI lowered the firm’s price target on Stryker (SYK) to $390 from $405 and keeps an Outperform rating on the shares. Recovering end markets and sector...